Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fondaparinux sodium (SR-90107A) is an antithrombin-dependent factor Xa inhibitor with antithrombotic activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 33.00 | |
2 mg | In stock | $ 46.00 | |
5 mg | In stock | $ 71.00 | |
10 mg | In stock | $ 129.00 | |
25 mg | In stock | $ 283.00 | |
50 mg | In stock | $ 492.00 | |
100 mg | In stock | $ 702.00 |
Description | Fondaparinux sodium (SR-90107A) is an antithrombin-dependent factor Xa inhibitor with antithrombotic activity. |
In vitro | Fondaparinux sodium is the first agent of a new class of anticoagulants that selectively target factor Xa. The IC50 values of Fondaparinux(anti-Xa IU/ml) are 0.59±0.05 for activated monocytes (ac-M) and 0.17±0.03 for monocyte-derived microparticles (MMPs)[2]. |
In vivo | Fondaparinux sodium has a linear, dose-dependent pharmacokinetic profile, which provides a highly predictable response. Fondaparinux sodium is 100% bioavailable, has a rapid onset of action, and has a half-life of 14 to 16 hours, allowing for sustained antithrombotic activity over a 24-hour period. The drug neither affects prothrombin time and activated partial thromboplastin time nor does it affect platelet function or aggregation[1]. |
Synonyms | Natural heparin pentasaccharide Sodium, Fondaparin sodium, SR-90107A, Arixtra |
Molecular Weight | 1729.09 |
Formula | C31H44N3Na10O49S8 |
CAS No. | 114870-03-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 17.36mM
DMSO: 0.6 mM
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fondaparinux sodium 114870-03-0 Metabolism Factor Xa inhibit Natural heparin pentasaccharide Sodium Fondaparin sodium Fxa Inhibitor Fondaparin Fondaparinux SR-90107A Arixtra inhibitor